logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

61L20/61M21
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Product Offerings

Products:

Tengzhou Xiangning Bioengineering Co., Ltd. (滕州市香凝生物工程有限责任公司), located in Tengzhou, Shandong Province, is a specialized pharmaceutical and bioengineering company known for its expertise in the development and production of gynecological and dermatological treatments. The company is positioned in the pharmaceutical manufacturing sector and primarily focuses on domestic distribution, with signs of expanding its footprint in global markets.

Company Background

Established with a focus on R&D-driven solutions for women’s health and skin conditions, Tengzhou Xiangning Bioengineering has built a reputation for producing high-quality, clinically tested medicinal products. With a clear emphasis on bioengineering and natural ingredient integration, the company aligns its operations with modern pharmaceutical standards.

Core Business

The company specializes in the manufacturing of gynecological, dermatological, and health-related medical preparations. Its product categories include:

  • Gynecological preparations: Antibacterial lotions, antifungal treatments, and vaginal health care solutions.
  • Dermatological solutions: Topical creams for dermatitis, eczema, and other skin conditions.
  • Health and hygiene products: Including herbal extracts and traditional Chinese medicine-based formulations.

Specialization and USP

Tengzhou Xiangning stands out in the market due to its integration of traditional Chinese medicine with modern pharmaceutical techniques. Their proprietary formulations, based on extensive research in natural compounds, offer alternatives to synthetic pharmaceutical products, particularly in gynecological care.

Their USP includes:

  • Use of herbal and plant-based extracts in pharmaceutical formulations.
  • Strong R&D capabilities with an emphasis on women's health.
  • Compliance with GMP (Good Manufacturing Practice) standards for pharmaceutical production.

Financials

While the company’s detailed financial reports are not publicly disclosed, its consistent presence in pharmaceutical exhibitions and listings in national medical product directories indicates stable operations and sustained growth. As a mid-sized enterprise in the bioengineering sector, its revenue is estimated to fall within the range of USD 5–10 million annually, based on comparable Chinese pharmaceutical SMEs.

Shipment & Export Records

According to trade data from platforms like Volza and ImportYeti:

  • Shipment focus: Predominantly domestic within China, with limited international exports.
  • International buyers: Preliminary export activity recorded to regions in Southeast Asia.
  • Total recorded exports: Fewer than 20 international shipments as of 2024, suggesting emerging export capabilities.

Target Market

  • Primary: Domestic pharmaceutical distributors, hospitals, and women’s health clinics across China.
  • Secondary: Distributors in Southeast Asia and developing nations looking for cost-effective, herbal-based gynecological treatments.

Capabilities

  • Full-cycle in-house production capabilities: from herbal extraction to formulation, packaging, and distribution.
  • Modern manufacturing units compliant with GMP standards.
  • A dedicated R&D team working on new applications of traditional Chinese medicine for modern health conditions.

Certifications and Compliance

  • Certified under GMP for pharmaceuticals in China.
  • Registered with the Shandong Provincial Drug Administration.
  • Products listed and approved under China’s National Medical Products Administration (NMPA).

Customer Testimonials

While formal testimonials are not readily available from global customers, online feedback from Chinese e-commerce platforms highlights:

  • Positive reviews for product effectiveness in treating common gynecological infections.
  • High repeat customer rates in domestic online stores like JD.com and Tmall.

Major Achievements

  • Selected as a featured pharmaceutical company in several regional pharmaceutical exhibitions across Shandong and broader China.
  • Acknowledged by local government initiatives supporting traditional Chinese medicine innovation.
  • Successfully developed multiple proprietary formulations combining bioengineering with traditional Chinese medicine principles.